More realistic power estimation for new user, active comparator studies: an empirical example

PURPOSE: Pharmacoepidemiologic studies are often expected to be sufficiently powered to study rare outcomes, but there is sequential loss of power with implementation of study design options minimizing bias. We illustrate this using a study comparing pancreatic cancer incidence after initiating dipe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmacoepidemiol Drug Saf
Asıl Yazarlar: Gokhale, Mugdha, Buse, John B., Pate, Virginia, Marquis, M. Alison, Stürmer, Til
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4788577/
https://ncbi.nlm.nih.gov/pubmed/26360635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.3872
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller